The placenta is known to protect the fetus from infection and maternal rejection.
INTRODUCTION
Placenta is a unique physical and immune barrier that protects the semiallogenic fetus in more than one way [1] . During human pregnancy, maternal immunoglobulin G (IgG) is transported from mother to fetus across the placenta to confer passive immunity to the fetus. On the one hand, it protects the fetus from infection, and on the other, it protects the fetus from immune rejection by the mother [2] . The mechanism of this delicate antibody selection, transportation, and blockage phenomenon across the placenta has not been fully understood.
The reported receptors of IgG Fc in trophoblasts are the neonatal Fc receptor (FcRn) and FccRIII [3] [4] [5] [6] [7] . FcRn is thought to transcytose maternal IgG across the syncytiotrophoblast layer to the fetal circulation [3] . Maternal IgG is internalized into endosomes present in the apical cytoplasm of the syncytiotrophoblast. At an acidic pH, it attaches to FcRn, which transports the IgG to the fetal site of the syncytiotrophoblast. Following fusion of the IgG-containing endosome with the cell membrane, IgG dissociates from FcRn at neutral pH [3] . The IgG receptor FccRIII is also detected in the syncytiotrophoblast layer, but its exact function is not known [4] . Previous studies reported that in the first trimester, very little IgG was in fetal serum. In the second trimester, the fetal serum IgG level was approximately 5%-10% of that of the maternal level. At term, the concentration of fetal serum IgG exceeded that of the maternal level, reaching 11.98 6 2.18 g/L. In early pregnancy, the concentration of IgG in maternal serum was 13.72 6 2.53 g/L. At term, the concentration of maternal serum IgG decreased to a level of 60%-70% of that of the early pregnancy [8] [9] [10] [11] [12] . Immunoglobulin A and IgM serum levels are very low in the fetus because they are not transferred across the placental barrier [13] . Most IgG present in fetal circulation is thought to be passively acquired, but some of it is synthesized by the fetus, as evidenced by the expression of fetal genetic markers of IgG molecules in fetal cord blood [14] . A previous study using radioimmunoelectrophoresis demonstrated that fetal IgG of the umbilical cord serum was relatively low before the 17th week of gestation but increased significantly after the 26th week of gestation [15] . Johnson et al. [16] examined genetic markers of IgG in the placenta and found that although IgG was mainly of maternal origin, nonmaternal (fetal) IgG was also present. Fetal IgG has long been thought to be produced only by fetal B lymphocytes residing in the liver, spleen, and lymph nodes [17, 18] . We previously obtained evidence of local production of IgG by the placenta, and a certain percentage of such placenta-derived IgG is glycosylated at one of its Fab fragments. The asymmetric IgG was found to react to immune cells and other antibodies and may play a role in placental immune evasion [18] .
Given the recent finding of IgG production by the placenta, we investigated the distribution of IgG and its mRNA at both the light microscopic (LM) and the electron microscopic (EM) levels to gain new insights into the aforementioned hypothesis. Two patterns of IgG distribution at the apical aspect of syncytiotrophoblasts were observed, and one of them (i.e., the irregularly shaped medium-electron density material) has not been reported previously. In addition, we also examined other immunoglobulin isotypes (IgM and IgA) and IgG Fc receptors, including FcRn and FccRIII, in placental villous trophoblasts. Furthermore, we studied the mRNA expressions of the constant region of the heavy chain of IgG1 (IGHG1), recombination activating gene 1 (RAG1), RAG2, and activation-induced cytidine deaminase (AID) with nested RT-PCR in primary trophoblast cell culture. Our findings suggest that two distinct molecular processes might take place in the trophoblast following the internalization of maternal IgG. Functional implications of this new phenomenon are discussed.
MATERIALS AND METHODS

Placenta Samples
Fresh human placenta samples were collected from the First Affiliated Hospital of Shantou University Medical College (Shantou, P.R. China). Fifteen first-trimester placentas (8-12 wk) and five second-trimester placentas (13-17 wk) were obtained from legally induced abortions. Fourteen term placentas (36-38 wk) were obtained from cesarean deliveries (12 cases) or natural deliveries (2 cases) of normal pregnancies. Human spleen samples were collected from autopsy at the Department of Forensic Medicine, Shantou University Medical College. Informed consent for the use of tissues for this study was obtained from all patients, and this study was approved by the ethics committee of Shantou University Medical College. All tissue samples were immediately dissected and processed on ice.
For light microscopy, the placental tissues were fixed in 4% paraformaldehyde in 0.01 M PBS (pH 7.4) at room temperature overnight. After washing in 0.01 M PBS, the samples were dehydrated in graded ethanol and embedded in paraffin.
For electron microscopy, the tissues were fixed in 2% paraformaldehyde with 0.2% glutaraldehyde in 0.1 M PBS (pH 7.4) at 48C overnight. After washing in 0.1 M PBS (pH 7.4), the samples were dehydrated in graded ethanol, and polymerized and embedded in LR White resin (Ted Pella, Inc.). A glass knife was used to cut semithin sections (1-2 lm), which were stained with toluidine blue and examined to select areas of interest. Finally, ultrathin (70-90 nm) sections, cut with a diamond knife, were collected on 200-mesh nickel grids.
Antibodies
For immuno-LM and immuno-EM (IEM), primary antibodies included placental alkaline phosphatase (PLAP; marker of syncytiotrophoblast), IgG, IgA, IgM, C1q, FcRn, and FccRIII. Secondary antibodies for immuno-EM included 20-nm gold-conjugated goat anti-rabbit IgG, 10-nm gold conjugated goat anti-rabbit IgG, 10-nm gold conjugated rabbit anti-goat IgG, and 10-nm gold conjugated goat anti-mouse IgG. All primary and secondary antibodies for EM were diluted in 5% bovine serum albumin/0.1% Tween 20 in 0.1 M PBS. More details of the antibodies used are presented in Supplemental Tables S1  and S2 (Supplemental Data are available online at www.biolreprod.org).
LM Immunohistochemistry
Tissue sections were deparaffinized and rehydrated, and then incubated with 3% hydrogen peroxide. Antigen retrieval was performed by heating the slides at 968C in 10 mM citrate buffer (pH 6.0) in a microwave oven for 20 min. The slides were washed with PBS and incubated with primary antibody overnight at 48C. After washing, the slides were incubated with the secondary antibody conjugated with peroxidase (reacts with both rabbit and mouse immunoglobulins; DAKO) and then colorized with 3-amino-9-ethylcarbazole (AEC) or 3, 3 0 -diaminobenzidine staining kit (DAKO). Human spleen samples obtained at autopsy were used as positive controls of immunoglobulin synthesis.
Immuno-EM
Dried ultrathin sections on grids were blocked with 5% bovine serum albumin in PBST (0.1% Tween 20 in 0.1 M PBS) for 1 h, followed by incubation with primary antibody overnight at 48C. The grids were then washed in PBST washing buffer and incubated in a 1:50 dilution of the gold-labeled secondary antibody for 1 h. The grids were thoroughly washed in washing buffer and then in distilled water. After air drying, the grids were stained with 5% uranyl acetate and viewed using a JEOL JEM-1400 transmission electron microscope (TEM) operated at 80 kV.
Double Immunolabeling of IEM
Double immunocytochemical labeling was performed according to the methods of Bendayan [19] , with modifications. Briefly, one side of the grid was exposed to the first primary antibody for 1 h at room temperature, and then incubated for 30 min at room temperature with 20-nm gold-conjugated anti-IgG antibody. After washing and drying, the grid was incubated with another primary antibody on the opposite side, followed by staining with 10-nm goldconjugated anti-IgG antibody. Each labeling was restricted to one side of the grid only. Then the section was stained with 5% uranyl acetate and viewed using a TEM operated at 80 kV.
LM In Situ Hybridization
Deparaffinized, rehydrated sections were incubated in 0.1 M HCl for 10 min, and then heated to 958C in a microwave oven in 0.01 M citrate buffer (pH 6.0) for 15 min. Tissue sections were incubated with cRNA probes to human IGHG1 as described by Chen and Gu [20] at 428C for 18 h. The sequences of the human IGHG1 primers are as follows: ACGGCGTGGAGGTGCATAATG (sense), CGGGAGGCGTGGTCTTGTAGTT (antisense). The probe was labeled with digoxigenin (Roche Diagnostics). Following hybridization, the slides were washed in 53 saline-sodium citrate (SSC) at 508C and 23 SSC plus 50% formamide, 23 SSC at 378C. After blocking with horse serum (1:100; Generay Biotech) at room temperature for 1 h, the slides were incubated with anti-digoxigenin-Ap Fab fragments (1:100; Roche Diagnostics) at room temperature for 1 h. The reaction was stained in nitro blue tetrazolium/5-bromo-4-choloro-3-indolyl phosphate (NBT/BCIP; Promega). For the control, slides were incubated with corresponding sense probes.
EM In Situ Hybridization
We also performed in situ hybridization (ISH) to examine IgG mRNA at the electron microscopic level. The cRNA probe against human IgG was produced as described previously [20] .
Electron microscopic ISH was performed on human placenta tissues following the protocol as described by Kitazawa and Kitazawa [21] , with modifications. Placental tissues were fixed in 2% paraformaldehyde with 0.2% glutaraldehyde in 0.1 M PBS (pH 7.4) at 48C overnight. After washing in 0.1 M PBS (pH 7.4) on ice, the samples were incubated in a prehybridization solution and treated in a microwave oven (2450 Hz, 800 W, 1 s on and 1 s off) for a total of 60 s. The samples were transferred into the hybridization medium (prehybridization solution:probe 2:8) at 508C for 18 h. After washing with 53 SSC at room temperature for 10 min, 50% deionized formamide/23 SSC, 23 SSC at 508C for 10 min, the samples were divided into two groups: one for LM observation (control) and the other for EM observation. For LM-ISH control, the sample was embedded in paraffin and cut into sections. Following hybridization, alkaline phosphatase-labeled goat anti-digoxigenin IgG antibody was used and the reaction products were colorized with NBT/BCIP, resulting in a purple-blue signal. For EM-ISH, the sample was embedded in LR White resin and cut into ultrathin sections. Following hybridization, mouse antidigoxigenin IgG antibody (Sigma) at 1:3000 dilution and goat anti-mouse IgG antibody labeled with 10-nm gold particles (Sigma) at 1:30 dilution were incubated sequentially. Then, the sections were treated with 2% glutaraldehyde containing 0.05% tannic acid (pH 5.5; Sigma) and 1% OsO 4 in 0.1 M PBS (pH 7.4) for 5 min each [22] , counterstained with 5% uranyl acetate, and viewed using the TEM operated at 80 kV.
Isolation and Purification of Trophoblasts
Eleven fresh placentas (5-12 wk) were washed with cold 13 PBS/1% penicillin-streptomycin (Life Technologies) three times and incubated in cold 13 PBS/10% penicillin-streptomycin for 10 min. The tissue was washed with LI ET AL. cold 13 PBS, dissected into small pieces, transferred into a 50-ml centrifuge tube, and centrifuged at 1000 rpm for 5 min. The tissue was next digested with 0.125% trypsin (Life Technologies) for 15 min at 378C. The digestion was stopped with Dulbecco modified Eagle medium (DMEM)/10% fetal bovine serum. The tissue was suspended in DMEM by several up-and-down runs with a pipette and was incubated for 2 min to let the tissue sink to the bottom. The suspension was transferred into a new tube and centrifuged at 2500 rpm for 5 min. The supernatant was discarded and the cells resuspended in DMEM. The cells were filtered through a cell strainer (pore size: 40 lm; BD Falcon) and centrifuged at 2500 rpm for 5 min. Cells were then diluted at 1 3 10 6 cells per milliliter with DMEM/F-12 /glutamine plus 1% antibiotics and antimycotics (Life Technologies), 1% non-essential amino acid (NEAA; Life Technologies), 5% low-IgG fetal bovine serum (Life Technologies), 5 ng/ml human epidermal growth factor (EGF; Sigma), and 1% insulin/transferrin/sodium selenite (Sigma). After seeding into a culture flask and incubation for 20 min in a humidified atmosphere with 5% CO 2 , most of the trophoblast cells adhered to the flask surface. The supernatant was then discarded and new medium was carefully added to the flask.
Nested RT-PCRs
Total RNA was extracted from primary cultured trophoblast cells using Trizol reagent (Invitrogen), and RT of total RNA was performed using the firststrand cDNA synthesis kit (TOYOBO) following the manufacturer's instructions. Nested PCRs were performed using a Taq PCR kit (NEB). The primers were prepared as described by Chen and Gu [20] and are listed in Supplemental Table S3 . CK7 was used as a marker for primary trophoblast cells. Raji cell line (B-cell lymphoma cell line) was used as a positive control for IGHG1, AID, RAG1, and RAG2. Fresh human liver tissue was used as a positive control for CK7. Amplification of the 18S gene was performed as an internal control. Negative control was amplified using diethyl pyrocarbonate (DEPC)-treated water as a template. The PCR products were separated on 2% agarose gel by electrophoresis.
Controls
For each immunohistochemistry (IHC) and IEM staining, the primary antibody was replaced with an irrelevant antibody or PBS as a negative control. The specificity of each primary Ig antibody was verified with Western blot analysis. Specific anti-human IgG, IgM, and IgA antibodies were used as the primary antibodies to detect the IgG, IgM, and IgA antigens, respectively. For ISH staining, a cRNA sense probe was used as a negative control.
RESULTS
Ultrastructural Observation
The human trophoblast was observed to be composed of two layers. The outer layer consists of syncytiotrophoblasts, which are multinucleated and have no cell borders between cells. Their cytoplasm contains many vacuoles and mitochondria are easily discernible (Supplemental Fig. S1 ). The inner layer is composed of mononucleated cytotrophoblasts, of which the overall electron density of the cytoplasm is lower than that of syncytiotrophoblasts, and which contain multiple organelles, including mitochondria, rough endoplasmic reticulum, and Golgi complex. The underlying villous basal membrane is in close contact with the cytotrophoblast layer, forming a continuous layer in the first trimester (Supplemental Fig. S1A ). In the second trimester, however, the layer is partly discontinuous, with interspersed syncytiotrophoblasts (Supplemental Fig. S1B ). In the third trimester, cytotrophoblast cells have mostly disappeared, with fetal vessels being in close proximity to the basal membrane. Toward the end of pregnancy, only one layer of syncytiotrophoblasts separates the maternal blood from the villous stroma of the placenta (Supplemental Fig. S1C ).
Immunohistocytochemistry
In first-trimester placentas, IgG (Igc) was chiefly localized to the cytoplasm of syncytiotrophoblast cells, whereas the cytotrophoblast cells and villous stroma were negative. In the second-trimester placenta, IgG was found not only in the cytoplasm of syncytiotrophoblasts, but also in the villous stroma. In full-term placentas, IgG was mainly observed in the plasma within the vessels of the villous stroma, and IgG staining in syncytiotrophoblasts was less intense compared with that seen in preterm placenta (Fig. 1) . In preterm placenta, IgG staining of syncytiotrophoblasts had a characteristic round, oil droplet-like appearance and was mainly confined to the apical cytoplasm adjacent to the maternal blood pool (Fig. 2A) .
Immunohistochemistry with antibody to IgM (Igl) showed that in all trimesters the syncytiotrophoblast was the sole cell type containing IgM immunoreactivity, and the positive granular particles were seen only in the apical cytoplasm of the syncytiotrophoblast. No IgM immunoreactivity was found within the villous stroma (Figs. 1 and 2B) . A similar finding was observed for IgA (Iga; Figs. 1 and 2C) . The IgM and IgA antibodies showed no cross-reactivity with each other or with the antibody to IgG, as confirmed by Western blot analysis (data not shown).
Complement C1q was localized to the cytoplasm of the trophoblast cells, endothelial cells, and Hofbauer cells in the villous stroma (Fig. 2D ).
Immunogold EM
Placental alkaline phosphatase, a marker for syncytiotrophoblasts, was localized to the apical cytoplasmic membrane and microvilli of syncytiotrophoblasts (Fig. 3A) . Cytotrophoblasts were negative.
In preterm and term placentas, IgG colloidal gold positivity was found in two different types of structures in the syncytiotrophoblast cytoplasm (Fig. 3, C and D) . Both were round, oval, or irregularly shaped but had different electron densities (i.e., low density and medium density). The lowelectron density structures, which were localized to the apical cytoplasm and were surrounded by a single membrane, appeared to be endosomes. The medium-electron density structures, which, to our knowledge, have not been previously reported in the literature, were uncoated and were morphologically similar to immune complex deposits as seen in the kidneys of patients with immune complex-mediated glomerulonephritis [23, 24] . They were mainly localized to the apical aspect of syncytiotrophoblast (Fig. 3 , C and D) and sometimes in proximity to the nucleus. In term placenta, the plasma in the vessels of the villous stroma showed intense IgG immunoreactivity, whereas the red blood cells (RBCs) were negative (Fig. 3, E and F) . The distribution of Igj (light chain of immunoglobulin) was similar to that of IgG (Fig. 3B) . Internalized IgG-positive microvilli were also observed (Fig.  3C) . The specificity of the immune reactivity was established with the results of the controls (Fig. 3, I and K).
C1q-positive staining was mainly confined to the mediumelectron density structures in the syncytiotrophoblasts but was absent from other ultrastructures (Fig. 3G ).
Immunogold staining with antibody to FcRn showed that the receptors were mainly localized to microvilli and lowelectron density cytoplasmic vesicles (Fig. 4A) . Endocytosis of FcRn-positive microvilli was readily observed (Fig. 4A) . However, the medium-electron density structures containing IgG immunoreactivity were negative for FcRn (Fig. 4B) . Occasionally, the cytoplasm of syncytiotrophoblasts was interspersed between two cytotrophoblasts, in which case the syncytiotrophoblastic cytoplasm and trophoblastic basal membrane contained FcRn immunoreactivity (Fig. 4C) . When the LI ET AL.
primary antibody was replaced with PBS, the immunostaining was negative (Fig. 4G) .
FccRIII (CD16) immunostaining showed a distribution pattern similar to that of FcRn, and the positivity was mainly confined to coated low-electron density vesicles. Similar to FcRn, the medium-electron density structures containing IgG immunoreactivity were negative for FccRIII (Fig. 4D) . We noted the presence of some FccRIII-positive endocytosed microvilli at the interface between syncytiotrophoblasts and cytotrophoblasts of first-trimester placentas (Fig. 4E) . The negative control using PBS instead of FccRIII antibody yielded negative results (Fig. 4F) .
The distributions of IgM and IgA were similar to each other, and both were localized to the medium-electron density structures at the apical cytoplasm of syncytiotrophoblasts, but not to the low-electron density structures (Fig. 3, H and J) . In addition, we noted endocytosed vacuoles containing IgMpositive microvilli at the apical cytoplasm of syncytiotrophoblasts (Fig. 3J) .
By double labeling with Igj and C1q (complement) labeled with two differently sized colloid gold particles, colocalization of immunoglobulin with complement was demonstrated in the medium-electron density structures of syncytiotrophoblasts, suggesting that such structures were composed of immune complexes (Fig. 5A ). Immunoglobulin G, IgM, and IgA were all detected in the medium-electron density amorphous structures (Fig. 5, C and D) . Although IgM and IgA were only observed in these structures, the staining of IgG was also present in the low-electron density structures (endosomes). Double labeling of IgG and FcRn showed that the mediumelectron density structures contained IgG immunoreactivity but were negative for FcRn. On the contrary, the low-electron density membrane-surrounded vesicles (endosomes) were positive for both IgG and FcRn (Fig. 5B ).
LM and EM In Situ Hybridization
Both LM-ISH and EM-ISH detected positive IGHG1 mRNA signals in syncytiotrophoblasts (Fig. 6 ), but not in cytotrophoblasts (Fig. 6, A and B) . The EM-ISH showed that the signals were present in the endoplasmic reticulum (Fig. 6C) of the syncytiotrophoblast cytoplasm.
Gene Expression of IGHG1, AID, RAG1, and RAG2 in Primary Trophoblasts
We evaluated the expression of IGHG1, AID, RAG1, and RAG2 mRNA in primary trophoblast cells by nested RT-PCR. AID is required for class switch recombination of Ig genes and somatic hypermutation in B lymphocytes. RAG1 and RAG2 are the initiators of the recombination of variable, diversity, and joining segments of Ig chains [20] . IGHG1, AID, RAG1, and RAG2 mRNA transcripts were all detected (Fig. 7) . Raji cell line was used as a positive control. CK7 primer was used to confirm the identity of the trophoblast cells. In addition, positive immunocytochemistry staining with rabbit anti-human CK7 and rabbit anti-human PLAP antibodies of primary trophoblasts directly grown on glass slides further confirmed that these cells were syncytiotrophoblasts (Supplemental Fig.  S2 ). And the PLAP-positive syncytiotrophoblasts also expressed the IgG mRNA by double labeling of ISH staining with IGHG1 cRNA probes and immunocytochemistry with PLAP antibody on primary trophoblast cell culture (Supplemental Fig. S2 ).
DISCUSSION
In this study, characteristic distribution patterns of IgG, IgM, and IgA, and related molecules (their mRNA, synthesizing enzymes, receptors, and complements) were obtained in trophoblasts of human placentas of all three trimesters at both the LM and the EM levels. The IgG distribution shows a gradual change of pattern during the progression of pregnancy. Of particular interest is that IgG was found to localize to two distinct subcellular structures: endosomes with FcRn and medium-electron density structures containing immune complexes with C1q. The IgM and IgA were confined to the medium-electron density structures in the syncytiotrophoblasts in all trimesters. To our knowledge, this is the first study in which double labeling and ISH were successfully performed at the ultrastructural level to study the placenta. While confirming the results of previous reports, new and significant observations with important functional implications were obtained.
Although the overall distribution pattern of IgG observed in this study is similar to that reported in previous EM studies [25] [26] [27] , a new pattern of distribution of IgG was identified. Immunoglobulin G immunoreactive gold particles were localized to two distinct structures. One of these structures was a membrane-coated vesicle with low electron density, surrounded by a membrane. Based on its morphology, this structure has previously been identified as the endosome [26] . FcRn and IgG were found colocalized within this structure. This observation is in accordance with the concept of FcRnmediated IgG transfer across the syncytiotrophoblast [3] . Binding of IgG to FcRn requires an acidic pH and is thought to occur in acidified endosomes of the syncytiotrophoblast [3, 28] . The second structure was of medium electron density without membrane coating. This structure has not been described in previous literature. Morphologically the medium-electron density structures showed great resemblance to immune complex deposits in the kidneys of patients with immune complex-mediated glomerulonephritis [23, 24] . Immunogold EM labeling demonstrated that the IgG-positive medium-electron density structures were devoid of FcRn, whereas they contained C1q immunoreactivity. The latter observation indicates that these structures most likely contained immune complexes. It is interesting to note that more than 30 yr ago, Faulk et al. [29] reported that the very apical aspect of syncytiotrophoblast contained small speckled areas of fluorescence reactivity with C1q in preterm placentas, which was then attributed to the pinocytotic activity of the plasma membranes of preterm trophoblasts.
Previous studies suggested that immune complexes in the placenta were likely composed of maternal anti-paternal major histocompatibility complex (MHC) antibodies and fetal (paternal) antigens expressed by stromal and endothelial cells in placental villous cores [30, 31] . Through the formation of immune complexes the placenta was thus thought to act as an ''antibody sink'' preventing detrimental maternal antibodies from entering the fetal circulation, where they could induce immune-mediated injury [29] . Evidence supporting the presence of maternal anti-paternal MHC antibodies in the placenta came from Doughty and Gelsthorpe [32] , who showed that some of the IgG eluted from placental samples had specificity for fetal MHC antigens.
In a previous study performed by our group, we provided an alternative explanation for the trapping of detrimental maternal antibodies. With an array of techniques, including ISH, RT-PCR, and EM, performed on the placental tissues, trophoblast cell lines, and placentas of muMT mice, we established that syncytiotrophoblasts can synthesize IgG. Furthermore, we IMMUNOGLOBULIN G IN PLACENTA FIG. 3 . Immuno-EM of human placenta. A) PLAP immunoreactivity in ultrathin sections of a term placenta. PLAP (10-nm gold) localizes to the apical cytoplasmic membrane and microvilli (M) of the syncytiotrophoblast. B) Colloidal gold-labeled Igj (10-nm gold) staining of a second-trimester placenta. Two kinds of electron density structures are identified: a medium-electron density structure (arrow), which is uncoated, and a low-electron density structure (arrowhead), which is membrane coated. The two structures both lie in the apical cytoplasm of the syncytiotrophoblast. C) Immunogold-labeled Igc (IgG; 20-nm gold) staining of a first-trimester placenta. Some gold particles are associated with the apical plasma membrane and microvilli (arrowheads), and some with endocytotic vesicles in the cytoplasm (white arrows). Medium-electron density structures (black arrows) are observed in the apical cytoplasm of the syncytiotrophoblast. N, nucleus. D) Colloidal gold-labeled Igc (10 nm) staining of a second-trimester placenta. There are two types of Igc-positive organelles in the apical cytoplasm of the syncytiotrophoblast: medium-electron density ones (arrows), which are uncoated, and lowelectron density ones (arrowheads), which are membrane coated. E and F) Colloidal gold-labeled Igc (10-nm gold) staining of a term placenta. E) Igc is localized to low-electron density (arrowhead) and medium-electron density (arrow) structures in the cytoplasm of a syncytiotrophoblast. Some of the Igc is freely scattered in the cytoplasm. F) Extensive IgG staining is apparent in the lumen of a blood vessel within the villous stroma. The RBCs lack immunoreactivity. G) Colloidal gold-labeled complement C1q (10-nm gold) staining of a second-trimester placenta. C1q is localized to medium-electron density structures (arrows), which are uncoated and located close to the nucleus (N) of the syncytiotrophoblast. N, nucleus. H) Immunogold-labeled Iga (IgA; 10-nm gold) staining of a second-trimester placenta. The majority of gold particles are seen in the medium-electron density structures (arrows) lying in the apical cytoplasm of the syncytiotrophoblast. The arrowhead indicates the nucleus. I) Negative control: replacement of the primary antibody with PBS in a term placenta. The secondary antibody is 10-nm gold-labeled goat anti-rabbit IgG. There is no immunoreactivity in the lumen of the villous LI ET AL.
demonstrated that the placenta-produced IgG was asymmetrically glycosylated IgG that was directed against white blood cells and other IgG molecules. In addition, such asymmetric IgG can act as blocking antibodies that do not trigger effector A, E, H, and K) and 500 nm (B-D, F, G, I, and J) .
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immune cells to carry out immune reaction [33, 34] . Taken together, these data suggested that maternal anti-paternal MHC antibodies might be sequestered in syncytiotrophoblasts by binding to these glycosylated antibodies produced by syncy- and FcRn (labeled with 10-nm gold particles) of a first-trimester placenta. In the apical cytoplasm of a syncytiotrophoblast, the medium-electron density structure (arrow) containing Igc immunoreactivity is negative for FcRn. On the contrary, the low-density structure (arrowhead) is positive for both Igc and tiotrophoblasts, hence forming immune complex deposits. Because syncytiotrophoblasts form the outer layer of the trophoblast barrier, which is directly exposed to the maternal blood, they are optimally located to carry out such an immune tolerance and protective function. This indicates that two different molecular sorting mechanisms might occur in the cytoplasm of syncytiotrophoblasts following maternal IgG internalization. The first sorting occurs in the endosome, in which the IgG binds to FcRn and is transported to fetal circulation. The second takes place in the cytoplasm, where placenta-produced glycosylated IgG might bind to detrimental maternal anti-paternal antibodies forming immune complexes. Previously, it was reported that such glycosylated antibodies would not cause immune effector reaction. This might constitute one possible mechanism of the placental immune evasion with which the placenta prevents the detrimental maternal antibody from crossing the placental barrier and protects the fetus from material rejection.
In our previous study we also used primary cultured trophoblasts to study IgG production. Positive IgG immunocytochemical and IGHG1 ISH signals were observed in primary cultured trophoblasts. Pulse-chase assay combined with the application of siRNA interfering with protein synthesis further confirmed IgG production by trophoblasts. In the present study, both IgG protein and its mRNA transcripts were identified in these cells. Furthermore, the detection of mRNA transcripts of AID, RAG1, and RAG2, all enzymes involved in Ig synthesis in B lymphocytes, provided additional evidence supporting local IgG production.
Similar to the fate of soluble immune complexes from the maternal circulation [31] , it is likely that the in situ-formed immune complexes, consisting of maternal anti-paternal antibodies and placenta-produced antibodies, are cleared by the numerous Hofbauer cells present in the placental villous core, given that these cells have phagocytotic capacities and express IgG Fc receptors [4] [5] [6] [7] 35] . This is the first EM study investigating the localization of FcRn at the ultrastructural level of the placenta. Expression of FcRn in syncytiotrophoblasts has previously been demonstrated with IHC, ISH, and flow cytometry [36, 37] , whereas colocalization of IgG and FcRn in syncytiotrophoblasts has been confirmed by multilabeling fluorescence IHC with confocal microscopy [38] . In these studies the presence of FcRn was confined to apical granules of the syncytiotrophoblasts and no FcRn reactivity was found on the cellular membrane surface. In the present study FcRn was not only detected in low-electron density vesicles in the apical cytoplasm of syncytiotrophoblasts, but also on microvilli on the apical cell membrane and in internalized microvilli. This is consistent with the results of Leach et al. [27] , who reported IgG localization on the surface of microvilli and in pits and invaginations of the syncytiotrophoblast surface using immunogold EM, suggesting that IgG receptors were diffusely distributed over the syncytiotrophoblast microvillous membrane. In the present study double immunogold labeling of FcRn and IgG showed that the location of IgG-positive immune complexes lacked FcRn staining, whereas the IgGpositive vesicles (endosomes) stained FcRn positivity. This observation is in agreement with the study of Kristoffersen and Matre [38] , who reported that not all of the IgG-positive granules they observed in the syncytiotrophoblast cytoplasm showed positive FcRn staining. The physiological significance of FcRn expression at the apical cell surface remains to be determined, because its expression appears to be at variance with established theories of receptor-independent internalization of IgG and pH-dependent interaction between IgG and FcRn.
FccRIII is another IgG Fc receptor expressed by trophoblasts [5-7, 26, 39] . Bright and Ockleford [26] and Bright et al. [39] showed that it is only expressed by syncytiotrophoblasts but not by cytotrophoblasts, and they detected colocalization of FccRIII and IgG in syncytiotrophoblasts using confocal immunofluorescence. Using IEM, we found that FccRIII was expressed at the apical microvillous membrane, and in invaginated pits and low-electron density vesicles (endosomes) of syncytiotrophoblasts, but not in the immune complex aggregations. It is conceivable that, given its expression in syncytiotrophoblasts and its colocalization with IgG in endosomes, FccRIII partially contributes to IgG transportation across the syncytiotrophoblast layer. This notion is supported by the detection of internalized FccRIII-positive microvilli at the interface between the syncytiotrophoblast and cytotrophoblast layers. However, experiments in pregnant FcRn knockout mice have shown that FcRn is the main receptor involved in IgG transfer in mice [40] . The high affinity of FccRIII for immune complexes, together with its expression on Hofbauer cells [5, 7] , suggests that FccRIII is essential for the clearance of immune complexes by Hofbauer cells in the villous stroma [4, 31] . Neither FccRI nor FccRII is expressed in trophoblasts [5] [6] [7] .
Our study showed a gradual change in the distribution of IgG during the progression of pregnancy. In first-trimester placentas IgG was only detected in syncytiotrophoblasts; in second-trimester placentas it was detected in both syncytiotrophoblasts and the villous stroma; and in term placentas IgG was mainly found in the plasma of villous core vessels, and to a much lesser extent in syncytiotrophoblasts. These changes in IgG distribution correlated with the changes of the cytotrophoblast layer, which forms a continuous layer underlying the syncytiotrophoblast sheet in the first trimester, breaks down slightly in the second trimester, and almost disappears at term. The cytotrophoblast cells were IgG negative in all three FIG. 7 . Expression of IGHG1, AID, RAG1, and RAG2 in primary cultured trophoblasts. DE-PC-treated water was used as a negative control. Raji was used as a positive control for IGHG1, AID, RAG1, and RAG2. CK7 primer was used as a trophoblast cell marker. Human liver tissue was used as a positive control for CK7.
IMMUNOGLOBULIN G IN PLACENTA trimesters of pregnancy. This is consistent with the findings in first-trimester and term placentas by Bright and Ockleford [26] and Bright et al. [39] , who suggested that cytotrophoblasts form a barrier to the transfer of maternally derived IgG across the placenta. Similar to Bright and Ockleford [26] and Bright et al. [39] , we observed that in first-trimester placentas the cytoplasm of some syncytiotrophoblasts penetrated between cytotrophoblasts and was in direct contact with the basal membrane, where trace amounts of FcRn immunoreactivity were detected. This suggests that small amounts of IgG may be transported across the trophoblast barrier through such direct contact of the syncytiotrophoblasts with the basal membrane, bypassing the cytotrophoblasts during the first trimester.
Because neither IgA nor IgM is transferred across the placental barrier, serum levels of IgM and IgA are very low in the fetus [13] . In this study, IgM and IgA were found to localize in the medium-electron density structures of the apical cytoplasm of syncytiotrophoblast. In contrast to IgG, IgM and IgA immunoreactivities were confined to the microvillous surface and the apical cytoplasm of the syncytiotrophoblast, and were not detected in the villous stroma. The distributions of IgM and IgA in the placenta have not been studied previously at the ultrastructural level. However, IgA has previously been detected in placental elutes [41] . In addition, apical granular IgA staining has been observed in term syncytiotrophoblasts with confocal microscopy [38] . Both IgM and IgA have been detected with IHC in the cytoplasm of chorionic trophoblasts of second-trimester placentas [42] . Many investigators have demonstrated the presence of IgG Fc receptors in syncytiotrophoblasts [3] , whereas receptors for IgM and IgA have not been identified in trophoblasts. We therefore suggest that, although syncytiotrophoblasts can internalize maternal serum containing IgA and IgM, these antibodies cannot be transported from the apical cytoplasm toward the fetal side of the syncytiotrophoblast because of a lack of specific receptors. Immunoglobulin M and IgA antibodies, however, do appear to form immune complexes with placenta-produced IgG, as evidenced by the characteristic granular, oil droplet-shaped appearance of IgM and IgA IHC staining along the plasma membrane surface and in the apical cytoplasm of syncytiotrophoblasts, and the aforementioned presence of IgM and IgA in the medium-electron density immune complexes. Immunoglobulin A and IgM are unlikely to be produced by placental syncytiotrophoblasts.
In summary, the ultrastructural study of IgG, its mRNA transcripts, its receptors, and the complement protein C1q indicates that two distinctly different molecular processes might take place in the syncytiotrophoblast following the internalization of IgG. The first sorting event involves endosomes, in which IgG binds to FcRn upon gradual acidification of the endosome, followed by transportation across the cytoplasm to the fetal side of the syncytiotrophoblast to confer passive immunity of the fetus. The second sorting event occurs in the cytoplasm, where IgG binds to placentaproduced IgG, forming immune complexes, which might subsequently be degraded and recycled by macrophages. The ultrastructural findings obtained in the present study therefore support the theory that placenta-produced IgG forms immune complexes with detrimental maternal anti-paternal antibodies, thus preventing them from reaching the fetal circulation. We hypothesize that this locally operative immune barrier may supplement other reported mechanisms [43, 44] and effectively protect the fetus from maternal immune rejection.
